Michael Makris

Glossop Road
Sheffield, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 155 publications

How real is the thrombotic risk with the rebalancing agents used to treat hemophilia?

How real is the thrombotic risk with the rebalancing agents used to treat hemophilia?

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 16, 2025

How real is the thrombotic risk with the rebalancing agents used to treat hemophilia?

How real is the thrombotic risk with the rebalancing agents used to treat hemophilia?

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 16, 2025

Is all the approved emicizumab dose essential?

Is all the approved emicizumab dose essential?

Journal: Journal of thrombosis and haemostasis : JTH

Published: November 10, 2025

Professor Eric Preston.

Professor Eric Preston.

Journal: Journal of thrombosis and haemostasis : JTH

Published: September 02, 2025

PF4-associated immune thrombocytopenia and thrombosis (PITT)-More than heparin and vaccines.

PF4-associated immune thrombocytopenia and thrombosis (PITT)-More than heparin and vaccines.

Journal: British journal of haematology

Published: April 13, 2025

Gynecologic and obstetric complications in women with congenital fibrinogen disorders: insights from the Prospective Rare Bleeding Disorders Database.

Gynecologic and obstetric complications in women with congenital fibrinogen disorders: insights from the Prospective Rare Bleeding Disorders Database.

Journal: Research and practice in thrombosis and haemostasis

Published: March 18, 2025

Inhibitor development in nonsevere hemophilia: data from the European Haemophilia Safety Surveillance (EUHASS) registry.

Inhibitor development in nonsevere hemophilia: data from the European Haemophilia Safety Surveillance (EUHASS) registry.

Journal: Research and practice in thrombosis and haemostasis

Published: January 31, 2025

Cryoprecipitate should not be the essential medicine recommended by the WHO to treat hemophilia.

Cryoprecipitate should not be the essential medicine recommended by the WHO to treat hemophilia.

Journal: Blood transfusion = Trasfusione del sangue

Published: December 05, 2024

High Prevalence of Platelet Function Disorders in Women Referred for Surgical Management of Refractory Heavy Menstrual Bleeding.

High Prevalence of Platelet Function Disorders in Women Referred for Surgical Management of Refractory Heavy Menstrual Bleeding.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: November 06, 2024

Trends in Treatment of Severe Haemophilia and Impact on Inhibitor Assessment by the EUHASS Registry.

Trends in Treatment of Severe Haemophilia and Impact on Inhibitor Assessment by the EUHASS Registry.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: October 23, 2024

Navigating the inevitable: artificial intelligence and the future of scientific communication.

Navigating the inevitable: artificial intelligence and the future of scientific communication.

Journal: Research and practice in thrombosis and haemostasis

Published: July 26, 2024

Learnings from the United Kingdom infected blood inquiry.

Learnings from the United Kingdom infected blood inquiry.

Journal: Research and practice in thrombosis and haemostasis

Published: May 21, 2024

Showing 1-12 of 155

Last Updated: 09/26/2026